Patrick Rene Angibaud,Olivier, Alexis Georges QUEROLLE,Didier Jean-Claude BERTHELOT,Christophe MEYER,Matthieu Philippe, Victor WILLOT,Lieven MEERPOEL,Thierry, François Alain, Jean JOUSSEAUME
申请号：
US16499421
公开号：
US20200181132A1
申请日:
2018.03.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula I)wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
